Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: Effect on urinary albumin excretion

Nephron

Volumn 80, Issue 3, 1998, Pages 277-284

  McAuliffe, Aileen V ^a  

^a Departments of A Life Sciences in Nursing   (Australia)

Author keywords

Albumin excretion; Aldose reductase inhibitors; Ascorbic acid; Proteoglycans

Indexed keywords

ALBUMIN; ALDOSE REDUCTASE INHIBITOR; ASCORBIC ACID; GLYCOSAMINOGLYCAN; HEMOGLOBIN A1C; HEPARAN SULFATE; PLACEBO; TOLRESTAT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADULT; AGED; ALBUMINURIA; ALDEHYDE REDUCTASE; ASCORBIC ACID; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PLACEBOS; PROTEOGLYCANS; TIME FACTORS;

EID: 0031726038     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045187     Document Type: Article

References (9)

1. Som S, Basu S, Mukherjee D, Deb S, Roy P, Choudhury PR, Mukhergee S, Chatterjee SN, Chatterjee IB: Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981;30:572-577.
2. Yue DK, McLennan S, Fisher E, Heffernan S, Capogreco C, Ross GR, Turtle JR: Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 1989;33:257-261.
3. Yue DK, McLennan S, Fisher E, Heffernan S, Capogreco C, Turtle JR: Abnormalities of ascorbic acid metabolism and diabetic control: Differences between diabetic patients and diabetic rats. Diabetes Res Clin Pract 1990;9:239-244.
4. Sinclair AJ, Girling AJ, Gray L, LeGuen C, Lunec J, Barnett AH: Distributed handling of ascorbic acid in diabetic patients with and without microangiography during high dose ascorbate supplementations. Diabetologia 1991;34:171-175.
5. Sinclair AJ, Taylor PB, Lunec J, Girling AJ, Barnett AH: Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabetologia 1994;11:893-898.
6. Giugliano D, Ceriello A: Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-267.
7. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22-28.
8. Schwartz E, Bienkowski RS, Coltoff-Schiller B: Changes in the components of extracellular matrix and in growth properties of cultured aortic smooth muscle cells upon ascorbate feeding. J Cell Biol 1982;92:462-470.
9. Hata R, Sunada H, Arai K, Sato T, Ninomiya Y, Nagai Y, Senoo H: Regulation of collagen metabolism and cell growth by epidermal growth factor and ascorbatc in cultured human skin fibroblasts. Eur J Biochem 1988; 173:261-267.